Drug Trial Radar · NCT06771128
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Last checked: Nov 19, 2026Latest source record: Jan 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
398
Actual
Start
Nov 1, 2024
Primary completion
Dec 1, 2025
Study completion Jan 1, 2026
Sponsor
- Lead sponsor
- Menoufia UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 13, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
the efficacy of Ginkgo Biloba versus desmopressin in treatment of children with monosymptomatic nocturnal enuresis
Conditions
- Nocturnal Enuresis in Children
- Desmopressin
- Monosymptomatic Nocturnal Enuresis
Interventions
Ginkgo Biloba oral tabletDrug
patients receive Ginkgo Biloba oral tablet 120 mg once daily
Desmopressin Acetate 0.2 mg TabletsDrug
patient receives desmopressin 0.2 mg oral tablet once daily
Ginkgo Biloba like PlaceboDrug
patients receive Ginkgo Biloba like Placebo oral tablet once daily
Desmopressin like PlaceboDrug
patients receive Desmopressin like Placebo oral tablet once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Night wetting frequencyTime frame: 1, 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Menoufia Faculty of Medicine
Shebin El-Kom, Menoufia, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.